India Glycols
- Market cap
- ₹ 1,927 Cr.
- P/E
- 7x
- P/B
- 0.68x
- 52-week range
- 160.37 – 399
- ROE
- 11%
- ROCE
- 12%
- Dividend yield
- 2.5%
- Debt / equity
- 0.58
- Sector
- Beverages
- Industry
- Breweries & Distilleries
- Listed on
- NSE, BSE
About
India Glycols Limited is an India-based green chemical company. The Company manufactures bio-based specialties and performance chemicals, such as green technology-based bulk, natural gums and industrial gases, potable spirits and Ennature biopharma. The Company's segments include Bio-Based Specialties and Performance Chemicals, Potable Spirits, and Ennature Biopharma. Bio-Based Specialties and Performance Chemicals include bio-based Glycols, Glycol Ethers, Glycol Ether Esters, Bio-Based Ethylene Oxide, and Power Alcohol (Biofuel). Potable Spirits include Indian Made Foreign Liquor (IMFL), branded Country liquor and Extra Neutral Alcohol (ENA). It serves various industries, including personal care, pharma and healthcare, textile, automotive, oil and gas, paint and coatings, food ingredients, industrial and manufacturing, and packaging. Its personal care includes biopolymer for cosmetics, extra neutral alcohol, liquid nitrogen, Sterigas, and bio carbon dioxide.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Breweries & Distilleries: 28 companies →India Glycols against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)7 against a typical 39.7: cheaper than most peers (1st = cheapest).3rd of 27
- Sales growth+8.7% against a typical +11.8% from a year earlier.14th of 25
- Profit growth+32.9% against a typical +10.1% from a year earlier.5th of 20
- Share price, 3 months+42.1% against a typical −9.2%.2nd of 28
- Size₹ 1,927.1 Cr. market value against a typical ₹ 419.4 Cr. (1st = largest).7th of 24
Credit ratings
Every rating action on file, newest first, including reaffirmations. Open a row for the agency's reasoning. All credit rating updates
No up-to-date rating
| Agency | Current rating | Outlook | As of |
|---|---|---|---|
| CARE | Withdrawn | — | 6 Mar 2026 |
Every agency has withdrawn its rating.
| Rating | Details | |||||
|---|---|---|---|---|---|---|
| 6 Mar 2026 | Withdrawn | was CARE A- (Rating Watch with Developing Implications) | — | CARE | ₹ 2,529.79 Cr. |
Board meetings
Results dates and other board meetings. Full calendar
| Details | ||
|---|---|---|
| 12 Aug 2026 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2026 |
| 14 May 2026 | Financial Results | To consider and approve the financial results for the period ended March 31, 2026 |
| 17 Mar 2026 | Dividend | To consider dividend |
| 10 Feb 2026 | Financial Results | To consider and approve the financial results for the period ended December 31, 2025 |
| 14 Nov 2025 | Financial Results | To consider and approve the financial results for the period ended September 30, 2025 |
| 16 Oct 2025 | Fund Raising | To consider Fund Raising |
Financials
Consolidated figures in ₹ crore.
| ₹ Cr. | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 775 | 904 | 926 | 969 | 961 | 975 | 863 | 1,040 | 1,092 | 1,102 | 976 | 1,130 |
| Expenses | 679 | 802 | 822 | 843 | 845 | 852 | 717 | 891 | 935 | 927 | 810 | 961 |
| Operating Profit | 96 | 102 | 105 | 126 | 116 | 124 | 146 | 150 | 158 | 175 | 166 | 170 |
| OPM % | 12% | 11% | 11% | 13% | 12% | 13% | 17% | 14% | 14% | 16% | 17% | 15% |
| Other Income | 12 | 9 | 10 | 14 | 15 | 19 | 13 | 20 | 14 | 3 | 14 | 21 |
| Interest | 29 | 31 | 33 | 36 | 40 | 44 | 45 | 45 | 49 | 47 | 26 | 25 |
| Depreciation | 28 | 26 | 26 | 28 | 28 | 27 | 33 | 34 | 38 | 41 | 41 | 42 |
| Profit before tax | 50 | 54 | 56 | 76 | 63 | 71 | 82 | 91 | 84 | 91 | 112 | 123 |
| Tax % | 24% | 23% | 24% | 20% | 22% | 20% | 22% | 19% | 22% | 25% | 23% | 21% |
| Net Profit | 38 | 42 | 42 | 60 | 50 | 57 | 64 | 73 | 65 | 68 | 87 | 97 |
| EPS in Rs | 6.14 | 6.73 | 6.82 | 9.75 | 8.03 | 9.18 | 10.34 | 11.83 | 10.51 | 10.08 | 12.96 | 14.45 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- 6%
- 5 Years
- 13%
- 3 Years
- 17%
- TTM
- 12%
- 10 Years
- 74%
- 5 Years
- 14%
- 3 Years
- 39%
- TTM
- 30%
- 10 Years
- 37%
- 5 Years
- 26%
- 3 Years
- 43%
- TTM
- —
- 10 Years
- 10%
- 5 Years
- 10%
- 3 Years
- 10%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| India Glycols | ₹ 329.00 | ₹ 1,927 Cr. | 7x | 0.7x | 11% | — |
| Asian Paints | ₹ 2,305.00 | ₹ 2,21,095 Cr. | 58.1x | 12.1x | 21.2% | 12.4% |
| Solar Industries India | ₹ 18,320.00 | ₹ 1,65,778 Cr. | 99.6x | 26.6x | 31.4% | 17.7% |
| Pidilite Industries | ₹ 1,514.00 | ₹ 1,54,107 Cr. | 64.8x | 14.7x | 23.8% | 16.9% |
| SRF | ₹ 2,309.00 | ₹ 68,444 Cr. | 44.6x | 6.1x | 13.8% | 11.6% |
| Linde India | ₹ 5,697.00 | ₹ 48,586 Cr. | 110.5x | 14.2x | 13.6% | 21.7% |
Management
- Uma Shankar Bhartia
- Executive Chairman of the Board, Managing Director
- Rupark Sarswat
- Chief Executive Officer
- Anand Singhal
- Chief Financial Officer
- Ankur Jain
- Compliance Officer, Company Secretary, Head - Legal
- Pragya Bhartia Barwale
- Whole-Time Director
- Alok Singhal
- Executive Director
Prices are delayed and for information only. Nothing on this page is investment advice.